Related Experiment Video
Updated: May 5, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
Camille Sibertin-Blanc, Emmanuelle Norguet, Muriel Duluc
1Assistance Publique - Hôpitaux de Marseille, Service d'oncologie digestive, Hôpital Timone, Université de la Méditerranée, Marseille, France. laetitia.dahan@mail.ap-hm.fr.
Background:
Novel therapeutic agents are currently being investigated for neuroendocrine tumour treatment.
Case Presentation:
We report here on the case of a patient presenting with hypersensitivity pneumonitis while being treated with everolimus, a mammalian target of rapamycin (mTOR) inhibitor.
Conclusion:
Side effects of everolimus should be familiar to clinicians, including nonspecialists, and be monitored carefully to allow for prompt management.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Hypersensitivity Reactions: Immune-Complex Reactions
Drug toxicity: Idiosyncratic Reactions